HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cornelius J Clancy Selected Research

polyglucosan

12/2019Rapid diagnosis of invasive candidiasis: ready for prime-time?
1/2018T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward.
2/2016Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management Strategies.
1/2016Diagnostic Methods for Detection of Blood-Borne Candidiasis.
1/2015Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens.
7/2014Undiagnosed invasive candidiasis: incorporating non-culture diagnostics into rational prophylactic and preemptive antifungal strategies.
5/2013Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.
5/2012Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cornelius J Clancy Research Topics

Disease

34Infections
01/2022 - 11/2005
18Candidiasis (Moniliasis)
01/2018 - 10/2003
14Candidemia
01/2019 - 08/2005
12Invasive Candidiasis
11/2021 - 05/2006
8COVID-19
10/2021 - 09/2020
7Mycoses (Diseases, Fungus)
06/2022 - 01/2010
6Communicable Diseases (Infectious Diseases)
01/2022 - 09/2015
6Bacteremia
08/2019 - 03/2015
4Pneumonia (Pneumonitis)
11/2021 - 01/2016
4Sepsis (Septicemia)
10/2021 - 09/2015
4Invasive Pulmonary Aspergillosis
01/2015 - 06/2007
3Urinary Tract Infections (Urinary Tract Infection)
10/2020 - 03/2017
2Coinfection
10/2021 - 09/2020
2Invasive Fungal Infections
01/2021 - 01/2010
2Neutropenia
01/2018 - 09/2010
2Abdominal Abscess
10/2017 - 09/2012
2Hematologic Neoplasms (Hematological Malignancy)
01/2015 - 07/2011
2Breakthrough Infections
12/2014 - 01/2014
2Skin Neoplasms (Skin Cancer)
12/2011 - 11/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2011 - 11/2010
2Neoplasms (Cancer)
11/2010 - 06/2010
1Mucormycosis
01/2022
1Liver Diseases (Liver Disease)
12/2021
1Empyema
04/2021
1Rupture
04/2021
1Clostridium Infections
01/2021
1Lung Diseases (Lung Disease)
01/2021
1Superinfection
12/2020
1Bacteriuria
10/2020
1Reinfection
01/2020
1Intraabdominal Infections
08/2019
1Respiratory Sounds (Crackle)
03/2017
1Pseudomonas Infections
01/2017
1Exanthema (Rash)
01/2017
1Drug-Related Side Effects and Adverse Reactions
12/2016
1Surgical Wound Infection
10/2016
1Cholangitis
09/2016
1Cystic Fibrosis (Mucoviscidosis)
01/2016

Drug/Important Bio-Agent (IBA)

13Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 01/2017
12Carbapenems (Carbapenem Antibiotics)IBA
01/2022 - 03/2015
11EchinocandinsIBA
11/2021 - 09/2012
9Pharmaceutical PreparationsIBA
12/2020 - 06/2010
8polyglucosanIBA
12/2019 - 05/2012
8Proteins (Proteins, Gene)FDA Link
01/2015 - 11/2005
7ceftazidime drug combination avibactamIBA
08/2019 - 12/2016
5Fluconazole (Zonal)FDA LinkGeneric
04/2021 - 08/2005
5galactomannanIBA
01/2015 - 06/2007
5Immunoglobulin G (IgG)IBA
05/2013 - 05/2006
4Biomarkers (Surrogate Marker)IBA
06/2022 - 05/2013
4AntigensIBA
10/2021 - 06/2003
4MannansIBA
02/2018 - 05/2013
4Caspofungin (Cancidas)FDA Link
12/2013 - 09/2012
3Antifungal AgentsIBA
06/2022 - 09/2015
3meropenem and vaborbactamIBA
01/2020 - 01/2019
3Colistin (Coly-Mycin)FDA Link
08/2019 - 06/2012
3ValganciclovirFDA Link
01/2014 - 09/2010
3Voriconazole (Vfend)FDA LinkGeneric
12/2011 - 01/2010
2AzolesIBA
11/2021 - 06/2010
2VaccinesIBA
10/2021 - 01/2021
2VancomycinFDA LinkGeneric
10/2021 - 01/2021
2BNT162 VaccineIBA
10/2021 - 01/2021
2Anti-Infective Agents (Microbicides)IBA
01/2021 - 01/2021
2PorinsIBA
01/2020 - 03/2015
2tazobactam drug combination ceftolozaneIBA
01/2018 - 01/2017
2posaconazoleFDA Link
01/2016 - 06/2010
2DoripenemFDA Link
03/2015 - 06/2012
2Antiviral Agents (Antivirals)IBA
08/2014 - 01/2014
2AnidulafunginFDA Link
12/2013 - 08/2009
2EnzymesIBA
08/2013 - 05/2008
2AntibodiesIBA
04/2009 - 11/2008
2Immunoglobulin M (IgM)IBA
05/2008 - 05/2006
2Virulence Factors (Pathogenicity Factors)IBA
08/2006 - 09/2005
1Prednisone (Sone)FDA LinkGeneric
11/2021
1DaptomycinFDA Link
10/2021
1Linezolid (Zyvox)FDA Link
10/2021
1Metronidazole (Metric)FDA LinkGeneric
01/2021
1FidaxomicinIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Polymyxin B (Aerosporin)FDA LinkGeneric
08/2019
1plazomicinIBA
08/2019
1Polymyxins (Polymyxin)IBA
08/2019
1avibactamIBA
01/2019
1Ceftazidime (Fortum)FDA LinkGeneric
01/2019
1isavuconazoleIBA
12/2018
1FosfomycinFDA Link
03/2017
1Meropenem (Merrem)FDA LinkGeneric
01/2017
1RNA (Ribonucleic Acid)IBA
09/2016
1AminoglycosidesIBA
01/2016

Therapy/Procedure

19Therapeutics
10/2021 - 08/2005
6Lung Transplantation
11/2021 - 01/2010
4Drug Therapy (Chemotherapy)
01/2018 - 06/2010
3Home Nursing (Nursing, Home)
10/2021 - 09/2020
1Bedding and Linens (Linens)
01/2022
1Transplantation
12/2021
1Urinary Catheters
10/2020
1Catheters
10/2020
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2018
1Duration of Therapy
01/2018
1Liver Transplantation
10/2016
1Aftercare (After-Treatment)
09/2016